Vericel (VCEL) Gross Margin Growth (1y) (2013 - 2026)

Vericel (VCEL) Gross Margin Growth (1y) (2013 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin Growth (1y) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 372.00
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -5.00
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -165.00
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 236.00
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Vericel 2.30 Bn 2.15 Bn 49.27 Mn 304.00

Historic Data

Download Data
DateValue
Mar 31, 2026 304.00
Dec 31, 2025 109.00
Sep 30, 2025 152.00
Jun 30, 2025 421.00
Mar 31, 2025 2.00
Dec 31, 2024 298.00
Sep 30, 2024 478.00
Jun 30, 2024 430.00
Mar 31, 2024 429.00
Dec 31, 2023 204.00
Sep 30, 2023 131.00
Jun 30, 2023 314.00
Mar 31, 2023 -76.00
Dec 31, 2022 108.00
Sep 30, 2022 30.00
Jun 30, 2022 -603.00
Mar 31, 2022 -294.00
Dec 31, 2021 -288.00
Sep 30, 2021 -690.00
Jun 30, 2021 1,136.00